20:53 , Dec 19, 2017 |  BC Innovations  |  Distillery Techniques

Biomarkers

TECHNOLOGY: Tissue markers Oligodendrocytes expressing BCAS1 could help monitor responses to remyelinating therapies in MS and other demyelinating diseases. In postmortem brain tissue samples from subjects without demyelinating diseases, high brain density of newly differentiated...
23:50 , Dec 6, 2017 |  BC Extra  |  Preclinical News

BCAS1 could identify remyelinating cells

In a paper published in Science Translational Medicine , researchers at the Max Planck Institute for Experimental Medicine and their German colleagues show that breast cancer amplified sequence 1 (BCAS1) can be used a marker...
07:00 , Apr 14, 2016 |  BC Innovations  |  Product R&D

AACR by the numbers

See Figure: Top indications See Table: Novel cancer targets at AACR 2016 See Figure: Top institutions and companies See Figure: Top targets Tables Novel cancer targets at AACR 2016 Breast cancer amplified sequence 1 (BCAS1)...